Sign in

CIK 0001826892

  • Non-accelerated filer
  • Smaller reporting company

BioAtla, Inc.

Sign in to watch
Ticker
BCAB
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851922320
Phone
+1 858-558-0708
Business address
11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
  1. 4 Open-market sale Chief Financial Officer sold 13,333 shares at an average $25.26 ($336,838)
  2. 4 Open-market sale Vasquez Christian sold 2,541 shares at an average $25.26 ($64,195)
  3. 4 Open-market sale President sold 1,580 shares at an average $25.26 ($39,916)
  4. 4 Open-market sale Chief Medical Officer sold 434 shares at an average $25.26 ($10,964)
  5. 4 Open-market sale Chief Executive Officer sold 57,640 shares at an average $25.26 ($1,456,182)
  6. 4 Open-market sale Director sold 450 shares at $30.00 ($13,500)
  7. 4 Open-market sale President sold 2,994 shares at $30.18 ($90,351)
  8. 4 Open-market sale Chief Medical Officer sold 592 shares at $30.39 ($17,993)
  9. 4 Grant or award Director acquired 267,900 shares (grant or award)
  10. 4 Open-market sale Director sold 450 shares at $36.82 ($16,569)
  11. 4 Open-market sale President sold 33,244 shares at an average $40.16 ($1,334,927)
  12. 4 Open-market sale Chief Medical Officer sold 6,883 shares at $39.59 ($272,496)
  13. 4 Open-market sale Director sold 546,709 shares at $39.65 ($21,677,012)
  14. 4 Open-market sale Chief Executive Officer sold 4,533 shares at $41.60 ($188,573)
  15. 4 Open-market sale Director sold 450 shares at $40.60 ($18,270)
  16. 4 Open-market sale Director sold 450 shares at $38.29 ($17,231)
  17. 4 Open-market sale Chief Executive Officer sold 74,269 shares at an average $39.16 ($2,908,126)
  18. 4 Open-market sale Director sold 400,000 shares at $39.16 ($15,664,000)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 13 of 15 · 293 filings